Pomalidomide is a medication used primarily in the treatment of multiple myeloma, a type of blood cancer. As patients and healthcare providers seek effective treatments, the role of manufacturers in producing high-quality and accessible medications like pomalidomide becomes essential.
Pomalidomide manufacturers are part of a class of drugs known as immunomodulatory agents. These medications work by modifying the immune system to help fight cancer cells more effectively. Pomalidomide helps inhibit the growth of cancer cells and promotes their death, making it a critical tool in treating multiple myeloma, especially in patients who have already received other therapies.